BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6588054)

  • 1. HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma.
    Prince HE; Schroff RW; Ayoub G; Han S; Gottlieb MS; Fahey JL
    J Clin Immunol; 1984 May; 4(3):242-5. PubMed ID: 6588054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection.
    Scorza Smeraldi R; Fabio G; Lazzarin A; Eisera NB; Moroni M; Zanussi C
    Lancet; 1986 Nov; 2(8517):1187-9. PubMed ID: 2877328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and Kaposi's sarcoma in Sardinia.
    Contu L; Cerimele D; Pintus A; Cottoni F; La Nasa G
    Tissue Antigens; 1984 Apr; 23(4):240-5. PubMed ID: 6587615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS.
    Mann DL; Murray C; Yarchoan R; Blattner WA; Goedert JJ
    J Acquir Immune Defic Syndr (1988); 1988; 1(1):13-7. PubMed ID: 3216293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5.
    Melbye M; Kestens L; Biggar RJ; Schreuder GM; Gigase PL
    Int J Cancer; 1987 Feb; 39(2):182-4. PubMed ID: 3492448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections.
    Pollack MS; Gold J; Metroka CE; Safai B; Dupont B
    Hum Immunol; 1984 Oct; 11(2):99-103. PubMed ID: 6333416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen associations of epidemic Kaposi's sarcoma.
    Ioannidis JP; Skolnik PR; Chalmers TC; Lau J
    AIDS; 1995 Jun; 9(6):649-51. PubMed ID: 7662207
    [No Abstract]   [Full Text] [Related]  

  • 8. Histocompatibility antigens HLA-A, -B, -DR in Greek patients with Kaposi's sarcoma.
    Papasteriades C; Kaloterakis A; Filiotou A; Economidou J; Nicolis G; Trichopoulos D; Stratigos J
    Tissue Antigens; 1984 Nov; 24(5):313-5. PubMed ID: 6335794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.
    Pollack MS; Safai B; Myskowski PL; Gold JW; Pandey J; Dupont B
    Tissue Antigens; 1983 Jan; 21(1):1-8. PubMed ID: 6601312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigen frequencies in HIV-1-related Kaposi's sarcoma.
    Mann DL; Murray C; O'Donnell M; Blattner WA; Goedert JJ
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S51-5. PubMed ID: 2395088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HLA typing in classical and African Kaposi's disease].
    Lemarchand-Venencie F; Lepace V; Belaich S; Civatte J; Rabian C; Chidiac A; Colombani J; Degos L
    Pathol Biol (Paris); 1986 Jun; 34(6):761-4. PubMed ID: 3531992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group.
    Plum G; Siebel E; Bendick C; Rasokat H; Braun M; Krickeberg H; Mauff G
    Vox Sang; 1990; 59 Suppl 1():15-20. PubMed ID: 2238573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic and immunogenetic studies in Kaposi's sarcoma].
    Kadagidze ZG; Kalamkarian AA; Kerimov SG; Derevnina NA; Mazina NM
    Vestn Dermatol Venerol; 1987; (11):15-20. PubMed ID: 3501921
    [No Abstract]   [Full Text] [Related]  

  • 14. [T-helper (CD4+) cytopenia and HLA-A1, -B8, -C27, -DR3].
    Kuntz BM; Sobieraj B; BrĂ¼ster HT
    Beitr Infusionsther Transfusionsmed; 1994; 32():310-3. PubMed ID: 9480115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA disease association and protection in HIV infection among African Americans and Caucasians.
    Cruse JM; Brackin MN; Lewis RE; Meeks W; Nolan R; Brackin B
    Pathobiology; 1991; 59(5):324-8. PubMed ID: 1910527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-DR5 with mycosis fungoides.
    Safai B; Myskowski PL; Dupont B; Pollack MS
    J Invest Dermatol; 1983 May; 80(5):395-7. PubMed ID: 6601679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma.
    Schroff RW; Gottlieb MS; Prince HE; Chai LL; Fahey JL
    Clin Immunol Immunopathol; 1983 Jun; 27(3):300-14. PubMed ID: 6603314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and immunogenetic features of primary Kaposi's sarcoma.
    Marinig C; Fiorini G; Boneschi V; Melotti E; Brambilla L
    Cancer; 1985 May; 55(9):1899-901. PubMed ID: 3156665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and Kaposi's sarcoma in solid organ transplantation.
    Brunson ME; Balakrishnan K; Penn I
    Hum Immunol; 1990 Sep; 29(1):56-63. PubMed ID: 2211190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
    J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.